MXPA01009384A - Composiciones farmaceuticas que comprenden un derivado de pirimidina y ciclodextrina. - Google Patents

Composiciones farmaceuticas que comprenden un derivado de pirimidina y ciclodextrina.

Info

Publication number
MXPA01009384A
MXPA01009384A MXPA01009384A MXPA01009384A MXPA01009384A MX PA01009384 A MXPA01009384 A MX PA01009384A MX PA01009384 A MXPA01009384 A MX PA01009384A MX PA01009384 A MXPA01009384 A MX PA01009384A MX PA01009384 A MXPA01009384 A MX PA01009384A
Authority
MX
Mexico
Prior art keywords
cyclodextrin
pyrimidine derivative
pharmaceutical compositions
compositions
haemorrhage
Prior art date
Application number
MXPA01009384A
Other languages
English (en)
Inventor
David John Heal
Original Assignee
Knoll Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Knoll Gmbh filed Critical Knoll Gmbh
Publication of MXPA01009384A publication Critical patent/MXPA01009384A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/40—Cyclodextrins; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Inorganic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

Una composicion farmaceutica que comprende a) un derivado de 1,2,4-triazolo(1,5-a) pirimidina de la formula (I) que incluye sales farmaceuticamente aceptables, racematos, enantiomeros, diastereoisomeros y mezclas de los mismos, b) una ciclodextrina. Estas composiciones son utiles en el tratamiento de la migrana, accesos y/o desordenes neurologicos tal como epilepsia y/o como agentes neuroprotectores para proteger contra las condiciones tales como ataque, trauma cerebral, lesiones de la cabeza y hemorragia en animales incluyendo los seres humanos.
MXPA01009384A 1999-03-18 2000-03-06 Composiciones farmaceuticas que comprenden un derivado de pirimidina y ciclodextrina. MXPA01009384A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9906126.9A GB9906126D0 (en) 1999-03-18 1999-03-18 Pharmaceutical formulations
PCT/EP2000/001940 WO2000056336A2 (en) 1999-03-18 2000-03-06 Pharmaceutical compositions comprising a pyrimidine derivative and cyclodextrin

Publications (1)

Publication Number Publication Date
MXPA01009384A true MXPA01009384A (es) 2004-03-19

Family

ID=10849799

Family Applications (1)

Application Number Title Priority Date Filing Date
MXPA01009384A MXPA01009384A (es) 1999-03-18 2000-03-06 Composiciones farmaceuticas que comprenden un derivado de pirimidina y ciclodextrina.

Country Status (8)

Country Link
EP (1) EP1161243A2 (es)
JP (1) JP2002539261A (es)
CN (1) CN1350456A (es)
AU (1) AU3286700A (es)
CA (1) CA2367040A1 (es)
GB (1) GB9906126D0 (es)
MX (1) MXPA01009384A (es)
WO (1) WO2000056336A2 (es)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9906130D0 (en) * 1999-03-18 1999-05-12 Knoll Ag Compounds for use in therapy
GB9914743D0 (en) * 1999-06-24 1999-08-25 Knoll Ag Therapeutic agents
AU2019240286A1 (en) 2018-03-23 2020-11-05 Bast Fibre Technologies Inc. Nonwoven fabric comprised of crimped bast fibers
EP3969639A1 (en) 2019-05-13 2022-03-23 Ecolab Usa Inc. 1,2,4-triazolo[1,5-a] pyrimidine derivative as copper corrosion inhibitor

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3346123A1 (de) * 1983-12-21 1985-06-27 Janssen Pharmaceutica, N.V., Beerse Pharmazeutische praeparate von in wasser schwerloeslichen oder instabilen arzneistoffen und verfahren zu ihrer herstellung
GB9321162D0 (en) * 1993-10-13 1993-12-01 Boots Co Plc Therapeutic agents

Also Published As

Publication number Publication date
WO2000056336A2 (en) 2000-09-28
JP2002539261A (ja) 2002-11-19
AU3286700A (en) 2000-10-09
EP1161243A2 (en) 2001-12-12
GB9906126D0 (en) 1999-05-12
CA2367040A1 (en) 2000-09-28
WO2000056336A3 (en) 2000-11-16
CN1350456A (zh) 2002-05-22

Similar Documents

Publication Publication Date Title
IL118836A (en) Pharmaceutical compositions comprising s-(-)-n-propargyl-1-aminoindan
WO2004020431A3 (en) Novel benzoimidazole derivatives useful as antiproliferative agents
WO2002042462A3 (en) Therapeutic agents and methods of use thereof for treating an amyloidogenic disease
GB9417532D0 (en) Aromatic compounds
WO2005056524A3 (en) Therapeutic agents useful for treating pain
CA2258548A1 (en) Phenylamino-substituted tricyclic derivatives for treatment of hyperproliferative diseases
BG106586A (en) Pyrazolopyramidines as therapeutic agents
WO2001009118A3 (en) Dithiolthione compounds for the treatment of neurological disorders and for memory enhancement
BG104561A (en) Aryl fused azapolycyclic compounds
HUT62262A (en) Process for producing amide composition and pharmaceutical compositions comprising same as active ingredient
MXPA05002420A (es) Compuestos de tiazol para el tratamiento de trastornos neurodegenerativos.
CA2501799A1 (en) Pyrazole compounds for treatment of neurodegenerative disorders
CA2326970A1 (en) Acetylene derivatives as anti-inflammatory/analgesic agents
AU697679B2 (en) Treatment of tinnitis using neuroprotective agents
IL111259A0 (en) Pyrimidine derivatives and pharmaceutical compositions comprising them
TW200509933A (en) Therapeutic agents
HUP0100024A3 (en) Pharmaceutical compositions for treating alzheimer's disease containing carvedilol as active ingredient
EP1032556A4 (en) PHARMACEUTICALLY EFFECTIVE COMPOUNDS AND METHODS OF THEIR APPLICATION
GB9310095D0 (en) Therapeutic compounds
CA2368165A1 (en) Salts of aminoimidazole carboxamide useful in the prevention and treatment of liver diseases
WO2002100836A8 (en) Compounds, compositions and methods for modulating beta-amyloid production
AU3218393A (en) N-substituted-dihydrobenzofuran derivatives as anti tumor compositions and methods of treatment
MXPA01009384A (es) Composiciones farmaceuticas que comprenden un derivado de pirimidina y ciclodextrina.
CA2192822A1 (en) Use of immunosuppressive agents for the treatment of schizophrenia
BG106180A (en) Pharmaceutical composition containing sibutramine and orlistat